The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374) ? Equipotent to PGI2 in vitro
- 1 January 1981
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 316 (3), 252-255
- https://doi.org/10.1007/bf00505658
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- dl-9a-deoky-9a-methylene PGI2 (a stable prostacyclin derivative): Preliminary pharmacological dataProstaglandins and Medicine, 1980
- Identification of the major metabolite of prostacyclin and 6-ketoprostaglandin F1α in manBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Prostacyclin deficiency in haemolytic-uraemic syndrome.BMJ, 1980
- 6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects.Hypertension, 1980
- Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitroEuropean Journal of Pharmacology, 1980
- 10,10-Difluoro-13-dehydroprostacyclin: a chemically and metabolically stabilized potent prostacyclinJournal of Medicinal Chemistry, 1980
- Circulatory and platelet actions of 6,9-Thiaprostacyclin (PGI2-S) in the catLife Sciences, 1979
- Metabolism of prostacyclin in ratBiochemistry, 1978
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- 6,9-Thiaprostacyclin. A stable and biologically potent analog of prostacyclin (PGI2)Journal of the American Chemical Society, 1977